Feeling weak on semaglutide is a concern reported by some patients using this GLP-1 receptor agonist for type 2 diabetes or weight management
Asilsoy, S., Bekem, O., Karaman, O., Uzuner, N., and Kavukcu, S
Ozempic European Medicines Agency medicine page
According to Shortlisters Workplace Wellness Report 2025, employer interest in weight management programs has more than doubled since 2021
Management of hyperglycemia in type 2 diabetes: a patient-centered approach position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Age-related changes in drug metabolism, altered light sensitivity, and interactions with commonly prescribed medications further contribute to heterogeneous responses